Zura Bio Limited (ZURA)
Last updated: 2026-10-20 23:04:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Zura Bio Limited (ZURA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $4.01, with a market capitalization of $371.82M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.15 to $7.44. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$371.82M | |
$3.83 | |
$37.55 | |
$0.97 | |
$3.81 | |
3.08M | |
2.11M | |
-- | |
$7.44 | |
$3.15 | |
-- | |
-- |
Zura Bio Limited (ZURA) After-Hours Stock Price
Zura Bio Limited (ZURA) is trading at $4.06 in after-hours trading as of 2026-10-20 22:59:00, up 6.51% ($0.25) from the regular-session close of $3.81.
After-hours trading shows how investors are pricing ZURA after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Zura Bio Limited (ZURA) 7-Day Stock Price Change
Over the past seven days, Zura Bio Limited (ZURA) moved from $4.00 to $4.01, representing a gain of 0.12% ($0.00).
The stock traded between $3.77 and $4.78 during the period. The latest price is near the lower end of the 7-day range, indicating range-bound.
The average daily volume was 6.85 million shares, up versus the previous seven-day period, indicating higher trading activity.
ZURA 52-Week Price Position
Position in Range: 19.9%
ZURA is currently trading at $4.01, placing it 19.9% of the way from its 52-week low of $3.15 to its 52-week high of $7.44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Zura Bio Limited (ZURA)?
Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.
Zura Bio Limited Information
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 40 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Zura Bio Limited (ZURA) Stock on MEXC
Eligible investors can buy real shares of Zura Bio Limited (ZURA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Zura Bio Limited (ZURA) stock price today?
2.Is ZURA stock going up or down today?
3.What is ZURA pre-market price?
4.What is ZURA after-hours price?
5.Is ZURA stock trading now?
6.Where does ZURA sit relative to its 52-week high and low?
7.What sector is Zura Bio Limited in?
8.What is Zura Bio Limited's market capitalization and where is it listed?
9.How is ZURA valued in terms of P/E ratio and EPS?
10.Does Zura Bio Limited pay a dividend?
Explore More US Stocks
Search Stocks
ZURA Stock Calculator
Estimate the value between ZURA shares and USD.
ZURA Shares to USD
1.00 ZURA shares = 4.005 USD
Calculations are estimates based on the latest available price and are for reference only.


